Gunderson Dettmer has advised Veza. ServiceNow (NYSE: NOW) has announced its acquisition of Veza, a leading AI-native identity security platform. The transaction, subject to customary regulatory...
ServiceNow Acquires AI-Native Identity Security Platform Veza
Colossal Biosciences’ $200 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Colossal Biosciences in the transaction. Colossal Biosciences, the world’s first de-extinction company, announced it raised $200 million in...
City Therapeutics’ $135 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented City Therapeutics in the transaction. City Therapeutics, a biopharmaceutical company, announced raising $135 million in Series A financing...
Veradigm’s $140 Million Acquisition of ScienceIO
McDermott Will & Emery represented Veradigm Inc. in the transaction, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ScienceIO. Veradigm Inc. (NASDAQ: MDRX) (the “Company”),...
Orbital Therapeutics’ $270M Series Financing
Gunderson Dettmer represented ARCH Venture Partners on the deal. ARCH Venture Partners led the $270 million Series A financing of Orbital Therapeutics, a company focused on enhancing...
Colossal Biosciences’ $150M Series B Financing
Gunderson Dettmer represented Colossal Biosciences on the deal. Colossal Biosciences, a genetic engineering company, announced its $150 million Series B financing led by United States Innovative Technology...
BigHat’s $75 Million Series B Financing
Gunderson Dettmer represented client Section 32 on the deal while Wilson Sonsini advised BigHat Biosciences. Section 32, a venture capital fund that invests in frontiers of...